Medical oncologist James Reeves, MD, a member of the clinical research team at Florida Cancer Specialists & Research Institute (FCS), is co-author of a study that examined the use and effectiveness of niraparib, a targeted therapy drug, to reduce the recurrence of HER2-negative, BRCA mutated breast cancer. Entitled, “Correlation Between Presence of Circulating Tumor DNA and Response to Neoadjuvant Niraparib in HER2-Negative, BRCA-Mutated Breast Cancer,” the study will be shared in a poster presentation at the San Antonio Breast Cancer Symposium being held Dec. 7 – 12, 2021.
A television commercial produced by Florida Cancer Specialists & Research Institute has been recognized in the 42nd Annual Telly Awards, which honors excellence in video and television as judged by leaders representing video platforms around the world.
Florida Cancer Specialists & Research Institute, LLC (FCS) today reported key quality and savings metrics as measured within the most recent performance period from The Centers for Medicare & Medicaid Innovation (CMMI) for the Oncology Care Model (OCM).
Florida Cancer Specialists & Research Institute (FCS) today held a ribbon-cutting ceremony to mark the opening of its new state-of-the-art cancer center in Manatee County.
Florida Healthcare Specialists (FHS), a division practice of Florida Cancer Specialists & Research Institute (FCS) located in Vero Beach, is proud to announce that urologist Hugo Davila, MD has been designated as the only Center of Excellence Physician in Indian River, St. Lucie and Martin Counties to offer Rezūm™ Water Vapor Therapy treatment.
Jessica Stine, MD, gynecologic oncologist with Florida Cancer Specialists & Research Institute (FCS), and an advanced robotic surgeon who performs the highest volume of GYN robotic surgery in the Tampa Bay area, has been designated as a National GYN Oncology Observation Site for Intuitive Surgical.
Florida Cancer Specialists & Research Institute (FCS) has opened its new state-of-the-art Trinity Cancer Center, providing the most advanced and personalized treatments and services for patients with all forms of cancers and blood disorders.
FCS Top News Updates
FCS Signals Next Chapter of Growth With Planned Leadership Transition and Focus on Innovation